BofA has reinstated coverage of 11 large-cap pharmaceutical and biotech stocks, with Eli Lilly (NYSE:LLY), Gilead ...
On Tuesday, Moderna Inc (MRNA) stock saw a decline, ending the day at $41.51 which represents a decrease of $-4.14 or -9.07% from the prior close of $45.65. The stock opened at $45.36 and touched a ...
BofA (BAC) analysts restarted their coverage on 11 large-capitalization pharmaceutical and biotech firms. The bad news was ...
Moderna (MRNA) shares tumble after Bank of America analysts reinstated its Underperform rating for the stock. In a broader note about the pharmaceutical and biotech spaces, Bank of America's team it's ...
BofA reinstated coverage of Pfizer (PFE) with a Neutral rating and $29 price target Uncertainty over COVID revenue streams plus a “tough” base ...
Wall Street's main indexes closed lower on Tuesday as technology sector losses offset gains in communications services while ...
BofA strategists led by David Hauner expect China’s yuan to bear the brunt, seeing the Chinese currency sliding to 7.6 per dollar in the first half of next year, should the incoming US ...
BofA analyst Curtis Nagle downgraded Duolingo (DUOL) to Neutral from Buy with a $375 price target Pick the best stocks and maximize your ...